Ekalia takes an important step in the deployment of Astatine-211 in the United States through a collaboration agreement with Telix

Ekalia, a joint venture between IBA and Framatome, has signed a collaboration agreement with Telix Pharmaceuticals to accelerate Astatine-211 production in the United States. The partnership will establish the first US production unit at RLS Trevose in Pennsylvania, with potential for further expansion. Telix will secure access to a portion of the production capacity to advance its alpha therapy pipeline.